Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • MDS-PAS 2024

    MDS-PAS 9th Annual Movement Disorders School: Empowering Neurology Residents for Patient Care

    Highlights from MJFF’s sponsored event, MDS-PAS 9th Annual Movement Disorders School for Neurology Residents on October 19-20. Read More.
    Learn more
  • Research Podcast Cover

    Episode 26: An Inside Look at the Edmond J. Safra Fellowship in Movement Disorders with Marcelo Merello and Sergio Castillo-Torres

    Dr. Marcelo Merello and Dr. Sergio Castillo-Torres share their insights and perspectives as a Fellowship Director and a Fellow in the program, respectively.
    Learn more
  • 2024 PDTC

    Sharing the Latest Insights at the 2024 Parkinson’s Disease Therapeutics Conference

    Sharing the Latest Insights at the 2024 Parkinson’s Disease Therapeutics Conference
    Learn more
  • Default content image

    In Memoriam: MJFF Mourns Loss of Parkinson’s Research Leader C. Warren Olanow, MD

    C. Warren OIanow, MD, participated early in The Michael J. Fox Foundation’s Scientific Advisory Board, offering guidance and leadership that left a lasting impact on Parkinson’s research. Learn more.
    Learn more
  • PPMI Data Shows Brain Changes Linked to Parkinson's Progression

    Data from Landmark MJFF Study Shows Impact of Promising Parkinson’s Therapy

    PPMI data on expected disease progression in Parkinson’s contrasts slower change in treatment group. Learn more.
    Learn more
  • Scientist in lab holding up blood sample

    What We Fund: $40.2M Toward Tools to Measure Parkinson’s and Therapies to Treat It

    The Michael J. Fox Foundation (MJFF) announces 129 grants that total more than $40.2 million awarded in August and September 2024.
    Learn more
  • Patient on bed speaking to a doctor

    FDA Approves New Infusion-based Treatment for Parkinson’s

    The U.S. Food and Drug Administration has approved Vyalev, the first under-the-skin levodopa/carbidopa infusion for Parkinson’s disease. Learn more.
    Learn more
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.